
Biomednewsbreaks Calidi Biotherapeutics Inc. (NYSE American: CLDI) Highlights 2025 Pipeline Progress And Strategic ...
(MENAFN- Investor Brand Network) Calidi Biotherapeutics (NYSE American: CLDI) , a clinical-stage biotech company developing systemic oncolytic targeted immunotherapies, released a shareholder letter from CEO Eric Poma, PhD, outlining a transformative year …